Vatsalya Vatsalya, Vatsalya Vatsalya, Fengyuan Li, Fengyuan Li, Jane Frimodig, Jane Frimodig, . . . Craig J. McClain. (2021). Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile. Frontiers Media S.A..
Chicago Style (17th ed.) CitationVatsalya Vatsalya, et al. Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationVatsalya Vatsalya, et al. Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile. Frontiers Media S.A., 2021.